For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221212:nRSL4015Ja&default-theme=true
RNS Number : 4015J Bank of America Merrill Lynch 12 December 2022
FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT
RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNIZED INTERMEDIARY
STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader Bank of America, N.A., Proprietary
Company dealt in HORIZON THERAPEUTICS PLC
Class of relevant security to which the Common - IE00BQPVQZ61
dealings being disclosed relate(Note 1)
Date of dealing 09/12/2022
Bank of America, N.A., Proprietary
Company dealt in
HORIZON THERAPEUTICS PLC
Class of relevant security to which the
dealings being disclosed relate(Note 1)
Common - IE00BQPVQZ61
Date of dealing
09/12/2022
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security
dealt in (Note 2)
Class of relevant security: Common IE00BQPVQZ61
Long Short
Number % Number %
(1) Relevant securities 120,573 0.053% 0 0 %
(2) Derivatives (other than options): 15,923 0.007% 17,871 0.008%
(3) Options and agreements to purchase/sell: 0 0% 0 0%
Total 136,496 0.06% 17,871 0.008%
120,573
0.053%
0
0 %
(2) Derivatives (other than options):
15,923
0.007%
17,871
0.008%
(3) Options and agreements to purchase/sell:
0
0%
0
0%
Total
136,496
0.06%
17,871
0.008%
(b) Interests and short positions in relevant securities of the company, other
than the
class dealt in (Note 2)
Class of relevant security:
Long Short
Number % Number %
(1) Relevant securities 0 0% 0 0%
(2) Derivatives (other than options): 0 0% 0 0%
(3) Options and agreements to purchase/sell: 0 0% 0 0%
Total 0 0% 0 0%
0
0%
0
0%
(2) Derivatives (other than options):
0
0%
0
0%
(3) Options and agreements to purchase/sell:
0
0%
0
0%
Total
0
0%
0
0%
3. DEALINGS (Note 3)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 4)
Purchase 1 96.91 USD
Purchase/sale Number of relevant securities Price per unit (Note 4)
Sale 1 96.91 USD
Sale 41 97.29 USD
Sale 437 96.67 USD
Sale 187 97.34 USD
Sale 200 96.02 USD
Sale 267 96.01 USD
Sale 6 96.11 USD
Sale 329 95.33 USD
Sale 100 96 USD
Sale 30 97.2 USD
Sale 50 97.3 USD
Sale 464 97.358 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD
(Note 5) (Note 6)
(Note 4)
Swaps Opening a Long Position 7,086 96.91 USD
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc Expiry date Option money paid/ received per unit (Note 4)
N/A N/A N/A N/A N/A N/A N/A
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option
unit (Note 4)
N/A N/A N/A
(d) Other dealings (including transactions in respect of new securities) (Note 3)
Nature or transaction Details Price per unit
(Note 7)
(if applicable) (Note 4)
N/A N/A N/A
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights
or future acquisition or disposal of any relevant securities to which any
derivative
referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 38.5(b) attached? (Note 8) No
Date of disclosure 12/12/2022
Contact name Hannah Chae
Telephone number +44207 995 0334
Name of offeree/offeror with which connected SANOFI SA
Nature of connection (Note 9) Advisor to - SANOFI SA
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ISEFLLFFLLLLFBQ